{"data":[{"accessionNo":"0000315066-26-002142","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"STRUCTURE THERAPEUTICS INC","ticker":"GPCR","cusip":"86366E106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":28197369,"percentOfClass":13.2,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000315066-26-002142","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"STRUCTURE THERAPEUTICS INC","ticker":"GPCR","cusip":"86366E106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":28197369,"percentOfClass":13.2,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":10437066,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":10437066,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":10437066,"percentOfClass":4.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":9637809,"percentOfClass":4.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":5583855,"percentOfClass":2.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":5583855,"percentOfClass":2.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4053954,"percentOfClass":1.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":4053954,"percentOfClass":1.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":643536,"percentOfClass":0.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000921895-26-000466","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":643536,"percentOfClass":0.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-26-000714","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":12335346,"percentOfClass":5.95,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-26-000714","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":12335346,"percentOfClass":5.95,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-26-000714","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":12335346,"percentOfClass":5.95,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-26-000082","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":21365952,"percentOfClass":10.1,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-26-000082","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":21365952,"percentOfClass":10.1,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-26-000082","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":21365952,"percentOfClass":10.1,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-26-000082","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":21365952,"percentOfClass":9.6,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000315066-26-000535","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"STRUCTURE THERAPEUTICS INC","ticker":"GPCR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":31112634,"percentOfClass":15,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000315066-26-000535","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"STRUCTURE THERAPEUTICS INC","ticker":"GPCR","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":31112634,"percentOfClass":15,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902664-25-004942","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Avoro Capital Advisors LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":16216665,"percentOfClass":9.38,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902664-25-004942","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Aghazadeh Behzad","reportingCik":null,"personType":"HC,IN","sharesOwned":16216665,"percentOfClass":9.38,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001274173-25-000299","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"STRUCTURE THERAPEUTICS INC","ticker":"GPCR","cusip":null,"securityClass":"American Depositary Shares","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":4448826,"percentOfClass":7.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-25-004826","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"David Kroin","reportingCik":null,"personType":"HC,IN","sharesOwned":12647433,"percentOfClass":7.32,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-25-004826","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Deep Track Capital, LP","reportingCik":null,"personType":"IA,OO","sharesOwned":12647433,"percentOfClass":7.32,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0001172661-25-004826","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Ordinary Shares, $0.0001 par value","eventDate":"2025-09-30","reportingPerson":"Deep Track Biotechnology Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":12647433,"percentOfClass":7.32,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000370","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":20631498,"percentOfClass":11.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000370","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":20631498,"percentOfClass":11.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000370","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":20631498,"percentOfClass":11.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000370","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":20631498,"percentOfClass":11.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000367","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":17067561,"percentOfClass":9.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000367","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":17067561,"percentOfClass":9.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000367","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":17067561,"percentOfClass":9.9,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"},{"accessionNo":"0000902219-25-000367","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001888886","issuerName":"Structure Therapeutics Inc.","ticker":"GPCR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":17067561,"percentOfClass":9.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr"}],"updatedAt":"2026-11-05T15:16:49.574Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/gpcr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}